Future

Ultrasound Treatment That Could Delay Dementia Now Moves To Human Trials

alzheimer-treatment-human-trials
PIxabay

Australian Federal Minister for Health Greg Hunt has announced he will be funding an ultrasound technique that could delay the effects of dementia. The funding, worth $10 million, will add up to the philanthropic  donations the University of Queensland – which has been developing the treatment – has received, rounding up the number to $30 million.

This money will be used to kickstart the human trials of the treatment, which initially used ultrasound to temporarily open the blood-brain barrier and help the antibodies that battle dementia reach the target within the brain. During studies on mice, the scientists realized that the ultrasound waves cleared toxic amyolic protein plaques from the brain without them having to administer any other sort of therapeutic drugs.

The human trials will involve a small number of patients that will explore if the technique is safe to use against the condition.

The technology temporarily opens the blood-brain-barrier to remove toxic plaques from the brain and has successfully reversed Alzheimer’s symptoms and restored memory function in animal models,” University of Queensland QBI Director Professor Pankaj Sah stated “The human safety trials late next year are the next step, representing an investment in research that is already underway.”

The funding will support a team of 90 researchers from QBI’s Clem Jones Centre for Ageing Dementia Research over the course of five years.

Also Read: ✍️A.I Can Predict Alzheimer’s Years Before Clinical Diagnosis✍️

✍️Test Detects Cancer in 10 Minutes by Analyzing Entire Genome✍️

Follow TechTheLead on Google News to get the news first.

Subscribe to our website and stay in touch with the latest news in technology.

Must Read

Are you looking for the latest innovations in tech? You're in the right place, just subscribe to our RSS feed


Techthelead Romania     Comedy Store

Copyright © 2016 - 2023 - TechTheLead.com SRL

To Top